CGA - glycoprotein hormones, alpha polypeptide Gene

Also Known as HCG; LHA; FSHA; GPA1; GPHa; TSHA; GPHA1; CG-ALPHA

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 1081

About CGA

Cytogenetic location: 6q14.3 Genomic coordinates (GRCh38): 6:87,085,498-87,095,106 (from NCBI)

This gene has 6 transcripts (splice variants) and 214 orthologues. Restricted expression toward placenta (RPKM 388.3).

Summary

The four human glycoprotein Hormones chorionic gonadotropin (CG), luteinizing hormone (LH), follicle stimulating hormone (FSH), and thyroid stimulating hormone (TSH) are dimers consisting of alpha and beta subunits that are associated noncovalently. The alpha subunits of these Hormones are identical, however, their beta chains are unique and confer biological specificity. The protein encoded by this gene is the alpha subunit and belongs to the glycoprotein Hormones alpha chain family. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2011]

CGA Products (2)

mRNA	Protein	Name
NM_000735.4	NP_000726.1	glycoprotein hormones alpha chain isoform 2 precursor
NM_001252383.2	NP_001239312.1	glycoprotein hormones alpha chain isoform 1 precursor

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables follicle-stimulating hormone activity	IDA IDA: Inferred from direct assay	2494176	GOA
enables hormone activity	IMP IMP: Inferred from mutant phenotype	11207219	GOA
enables protein binding	IPI IPI: Inferred from physical interaction	7922031	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in G protein-coupled receptor signaling pathway	IDA IDA: Inferred from direct assay	24692546	GOA
involved in positive regulation of steroid biosynthetic process	IDA IDA: Inferred from direct assay	2494176	GOA
involved in regulation of signaling receptor activity	IDA IDA: Inferred from direct assay	24692546	GOA

Cellular Component GO Annotation	Evidence	References	Source
located in extracellular space	IDA IDA: Inferred from direct assay	2494176	GOA
part of follicle-stimulating hormone complex	IDA IDA: Inferred from direct assay	2494176	GOA
part of follicle-stimulating hormone complex	IPI IPI: Inferred from physical interaction	11222739	GOA
part of pituitary gonadotropin complex	IPI IPI: Inferred from physical interaction	7922031	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

CGA Protein Structure

Hormone_6

0
100
116 a.a.

Protein Preferred Names	Protein Names
glycoprotein hormones alpha chain	FSH-alpha

CGA Protein-protein interaction Information

Type	Protein Name	Protein ID	Interactor	Interactor Species	Interactor ID	Detection Method	References
Intra	CGA	P01215	FSHB	Homo sapiens	P01225	X-Ray Diffraction	11222739
Intra	CGA	P01215	CGB5	Homo sapiens	P0DN86	SLC	31467278
Intra	CGA	P01215	CGB5	Homo sapiens	P0DN86	X-Ray Diffraction	7922031

Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant CGA Proteins

Cat. No.	Product Name	Accession	Purity
HY-P7869	CG alpha Protein, Human (HEK293, His)	P01215 (A25-S116)	≥ 95%, as determined by reducing SDS-PAGE.
HY-P7870	CGA-CGB3 Heterodimer Protein, Human (HEK293, His)	P01215 (A25-S116)&P0DN86 (S21-Q165)	≥ 90%, as determined by reducing SDS-PAGE.
HY-P70237	FSH Protein, Human (HEK293, Flag-His)	P01215 (A25-S116)&P01225 (N19-E129)	≥ 95%, as determined by reducing SDS-PAGE.
HY-P74133	FSH Protein, Human (HEK293, Fc)	P01215 (A25-S116)&P01225 (N19-E129)	≥ 95%, as determined by reducing SDS-PAGE.
HY-P75341	CG alpha Protein, Human (HEK293, mFc)	P01215 (A25-S116)	≥ 90%, as determined by reducing SDS-PAGE.
HY-P75342	CG alpha Protein, Human (HEK293)	NP_000726.1 (A25-S116)	≥ 90%, as determined by reducing SDS-PAGE.

CGA Antibodies

Cat. No.	Product Name	Application	Reactivity
HY-P85956	CGA/hCG alpha Antibody (YA5648)	IHC-P, WB, ICC/IF, ELISA	Human
HY-P86714	CGA/hCG alpha Antibody (YA6406)	IHC-P, IHC-F, ICC/IF, ELISA	Human
HY-P86714A	CGA/hCG alpha Antibody (YA6406)(PBS only)	IHC-P, IHC-F, ICC/IF, ELISA	Human

Related Diseases

Diseases	Alias
Ectopic Pregnancy	Eccyesis Pregnancy Ectopic Pregnancy, Ectopic Ectopic Pregnancies Extrauterine Gestation Or Pregnancy Extrauterine Pregnancy Ep - [Ectopic Pregnancy] Ectopic Mole Aborted Ectopic Pregnancy Ruptured Ectopic Pregnancy
Ovarian Hyperstimulation Syndrome	OHSS Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous Secondary Meig'S Syndrome Ohss - [Ovarian Hyperstimulation Syndrome] Hyperstimulation Of Ovaries Nos Hyperstimulation Of Ovaries Associated With Induced Ovulation
Ovarian Disease	Ovarian Dysfunction Ovarian Diseases Ovarian Disorders Disorder Of Endocrine Ovary
Germ Cell Cancer	Malignant Germ Cell Tumor Neoplasms, Germ Cell And Embryonal Germ Cell Neoplasm Germ Cell Tumour Malignant Tumor Of The Germ Cell Neoplasms Germ Cell Malignant Germ Cell Neoplasm
Germinoma
Anovulation
Choriocarcinoma	Chorioepithelioma
Hydatidiform Mole, Recurrent, 1	Hydatidiform Mole Gestational Trophoblastic Disease Complete Hydatidiform Mole Hydm HYDM1 Chm Molar Pregnancy Hydatidiform Mole, Complete Hydatid Mole Complete Molar Pregnancy Mole, Hydatidiform, Recurrent, Type 1 Gestational Trophoblastic Neoplasms Hydatidiform Mole, Recurrent, 2 Classical Hydatidiform Mole
Polycystic Ovary Syndrome	Polycystic Ovarian Syndrome Pcos Polycystic Ovarian Disease Polycystic Ovaries Stein-Leventhal Syndrome Multicystic Ovaries Polycystic Ovary Sclerocystic Ovaries Sclerocystic Ovary Syndrome Stein-Leventhal Synd. Cystic Disease Of Ovaries Cystic Disease Of Ovary Pco Pcod Sclerocystic Ovarian Degeneration Polycystic Ovary Syndrome, Susceptibility To Pcos - [Polycystic Ovary Syndrome] Polycystic Ovary Nos Pco - [Polycystic Ovary]
Ovarian Mixed Germ Cell Neoplasm	Mixed Germ Cell Tumor Of Ovary Ovarian Mixed Germ Cell Tumor
Orofaciodigital Syndrome Viii	Edwards Syndrome Trisomy 18 Complete Trisomy 18 Syndrome OFD8 Orofaciodigital Syndrome 8 Trisomy 18 Syndrome Oral-Facial-Digital Syndrome With Hypoplastic Epiglottis E3 Trisomy Oral-Facial-Digital Syndrome Type 8 Orofaciodigital Syndrome Type 8 Ofds Viii Oral-Facial-Digital Syndrome, Type Viii Ofd Syndrome 8 Ofds 8 Oral Facial Digital Syndrome 8 Oral Facial Digital Syndrome Type 8 18 Trisomy Chromosome 18 Trisomy Trisomy 16-18 Trisomy E Trisomy E Syndrome Chromosome 18 Duplication Oral-Facial-Digital Syndrome, Edwards Type Orofaciodigital Syndrome, Edwards Type Chromosome 18, Trisomy Cleft Lip/Palate With Abnormal Thumbs And Microcephaly Trisomy 18 Chromosome Abnormal Autosomes 18
Teratoma	Teratomas
Hyperthyroidism	Overactive Thyroid
Gestational Trophoblastic Neoplasm	Hydatidiform Mole Molar Pregnancy Gestational Trophoblastic Neoplasia Gestational Trophoblastic Tumor Gtn Gestational Trophoblastic Disease Gestational Trophoblastic Neoplasms Hydatidiform Mole, Recurrent, 1 Hydatidiform Mole Benign Trophoblastic Disease Trophoblastic Disease Nos Trophoblastic Disorder Vesicular Mole Nos Vesicular Mole Hydatidiform Mole Nos
Trophoblastic Neoplasm	Trophoblastic Tumor Trophoblastic Neoplasms
Gynecomastia
Androgen Insensitivity Syndrome	Androgen Resistance Syndrome AIS Testicular Feminization Syndrome Androgen Receptor Deficiency Dhtr Deficiency Dihydrotestosterone Receptor Deficiency Ar Deficiency Testicular Feminization Tfm Androgen Insensitivity Androgen-Insensitivity Syndrome Goldberg-Maxwell Syndrome Complete Androgen Insensitivity Syndrome Cais Feminisation - Testicular Goldberg - Maxwell Syndrome Androgen Insensitivity Syndrome, Complete Morris Syndrome Ary AR Insensitivity Syndrome, Androgen Androgen Insensitivity Nos
Seminoma	Seminoma, Pure
Testicular Cancer	Testis Cancer Testicular Carcinoma Testicular Neoplasms Malignant Neoplasm Of Testis Childhood Neoplasm Of The Testis Neoplasm Of Testis Pediatric Testicular Neoplasm Testicular Tumor Testis Neoplasm Testicular Tumors Testicular Neoplasm Testicular Malignant Germ Cell Tumor Childhood Testicular Neoplasm Carcinoma Of The Testis Cancer Of Testis Malignant Neoplasm Of Testis, Nos Malignant Neoplasm Of Testis, Unspecified Malignant Tumour Of Testis Testicle Cancer Primary Malignant Neoplasm Of Testis
Hypothyroidism	Thyroid Diseases Thyroid Disease Thyroid Deficiency Thyroid Insufficiency Dysfunction Thyroid Thyroid Dysfunction
Hyperprolactinemia	Chiari-Frommel Syndrome Hyperprolactinaemia Familial Hyperprolactinemia HPRL Pregnancy-Related A-G Syndrome Familial Isolated Prolactin Receptor Deficiency
Infertility
Varicocele	Scrotal Varices Varicoceles Varicocele Of Scrotum Scrotal Varicocele
Complete Androgen Insensitivity Syndrome	Cais Complete Androgen Resistance Syndrome Androgen Insensitivity Syndrome Complete Androgen Insensitivity, Complete Androgen-Insensitivity Syndrome Testicular Feminization
Luteoma	Leuteoma Of Pregnancy Luteoma Of Pregnancy
Down Syndrome	Trisomy 21 Complete Trisomy 21 Syndrome Down'S Syndrome Trisomy 21 Syndrome Down'S Syndrome - Trisomy 21 Downs Syndrome G Trisomy 47,Xx,+21 47,Xy,+21 Trisomy G Down Syndrome, Susceptibility To Chromosome 21 Trisomy Trisomy 21 Nos Abnormal Autosomes 21
Placenta Disease	Placenta Diseases Placenta Disorder Pregnancy Complications Placenta Disorders
Cataract 4, Multiple Types	Cataract 4 Multiple Types CTRCT4 Cca3 Pcc Aculeiform Cataract Cataract 4, Multiple Types, With Or Without Microcornea Cataract, Crystalline Aculeiform Caca Cataract, Congenital, Cerulean Type, 3 Congenital Cataract Cerulean Type 3 Cataract Congenital Dominant Non Nuclear Ccp Cataract, Nonnuclear Polymorphic Congenital Cataract, Punctate, Progressive Juvenile-Onset Cataract 4 Multiple Types With Or Without Microcornea Autosomal Dominant Nonnuclear Polymorphic Congenital Cataract Cataract, Polymorphic Congenital Congenital Cataract Blue Dot Type 3 Congenital Non-Nuclear Polymorphic Cataract Crystalline Aculeiform Cataract Punctate, Progressive Juvenile-Onset, Cataract Cataract, Nonnuclear Polymorphic Congenital, Autosomal Dominant
Hydrocele	Testicular Hydrocele
Endometriosis	Endometriosis, Site Unspecified Endometrial Ectopia
Placental Insufficiency	Uteroplacental Vascular Insufficiency
Oligohydramnios	Oligohydramnios - Delivered Antepartum Oligohydramnios Delivered Oligohydramnios Oligohydramnios, Antepartum Condition Or Complication Deficient Liquor Oligohydramnios, Unspecified Trimester Reduced Liquor Volume
Patellofemoral Pain Syndrome
Glutaric Aciduria Iii	Glutaryl-Coa Oxidase Deficiency Ga Iii Glutaric Acidemia Type 3 GA3 Glutaric Aciduria Type 3 Glutaric Aciduria 3 Glutaric Acidemia Type Iii Glutaric Aciduria Type Iii
Penis Agenesis	Micropenis Agenesis Of The Penis Penis Agenesia
Neuroendocrine Tumor	Neuroendocrine Neoplasm Neuroendocrine Tumors Carcinoma, Neuroendocrine
Pre-Eclampsia	Preeclampsia Gestational Hypertension Hypertension Induced By Pregnancy Pre-Eclamptic Toxaemia Pregnancy Associated Hypertension Proteinuric Hypertension Of Pregnancy Hypertension, Pregnancy-Induced, Susceptibility To Preeclampsia/Eclampsia Pregnancy Toxemia Toxaemia Of Pregnancy Gestational Proteinuric Hypertension Pregnancy-Induced Hypertension Toxemia Of Pregnancy Preeclampsia, Susceptibility To Transient Hypertension Of Pregnancy Gestational [Pregnancy-Induced] Hypertension Without Significant Proteinuria Gestational Hypertension Nos Mild Proteinuric Hypertension Of Pregnancy Pih - [Pregnancy-Induced Hypertension] Pregnancy-Induced Hypertension Nos Gestational [Pregnancy-Induced] Hypertension With Significant Proteinuria Pe - [Pre-Eclampsia] Pre-Eclampsia Nos Pre-Eclamptic Nos Pregnancy Pre-Eclampsia Puerperal Pre-Eclampsia Pre-Eclampsia Toxaemia Toxaemia In Pregnancy Pet - [Pre-Eclamptic Toxaemia] Maternal Toxaemia
Ovarian Cyst	Ovarian Cysts
Cryptorchidism, Unilateral Or Bilateral	Cryptorchidism Undescended Testicle Undescended Testis Cryptorchism Undescended Testicles CRYPTO Impaired Testicular Descent Cryptosporidiosis Retained Testis Unilateral Cryptorchidism Unilateral Undescended Testis Nondescent Unilateral Testicle Unilateral Cryptorchism Ectopic Testis, Unilateral Bilateral Cryptorchidism Bilateral Cryptorchism Bilateral Nondescent Testicle Bilateral Undescended Testes Bilateral Ectopic Testes
Pituitary Gland Disease	Pituitary Diseases Pituitary Dysfunction Pituitary Disease Pituitary Deficiency Pituitary Disorders
Cystinosis	Cystine Storage Disease Cystine Diathesis Cystine Disease Cystinoses Protein Defect Of Cystin Transport Cystin Transport, Protein Defect Of Nephropathic Cystinosis Protein Defect Of Cystine Transport
Hemophagocytic Lymphohistiocytosis, Familial, 3	Familial Hemophagocytic Lymphohistiocytosis 3 FHL3 Hplh3 Hlh3 Lymphohistiocytosis, Hemophagocytic, Familial, Type 3
Placental Site Trophoblastic Tumor	Trophoblastic Tumor Placental Site Trophoblastic Tumor, Placental Site Placental Site Trophoblastic Tumour Placental-Site Gestational Trophoblastic Neoplasm Placenta Neoplasm Psst Deciduoma Placental Cancer Primary Malignant Neoplasm Of Placenta
Placental Abruption	Abruptio Placentae Abruptio Placenta Abortion, Threatened Threatened Miscarriage Haemorrhage Specified As Due To Threatened Abortion Spontaneous Threatened Abortion
Asperger Syndrome	Asperger Disorder Asperger Syndrome, Susceptibility To
Kallmann Syndrome	Hypogonadism With Anosmia Kallman'S Syndrome Anosmic Hypogonadism Anosmic Idiopathic Hypogonadotropic Hypogonadism Hypogonadotropic Hypogonadism And Anosmia Hypogonadotropic Hypogonadism-Anosmia Syndrome Olfacto-Genital Pathological Sequence Familial Hypogonadism With Anosmia Kallman Syndrome Dysplasia Olfactogenitalis Of De Morsier Kallmann'S Syndrome Congenital Hypogonadotropic Hypogonadism With Anosmia

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B0621	Triclabendazole	Inhibitor	99.36%	Yes

Clinical Phase

Bioactive Molecules (4)

Cat. No.	Product Name	Effect	Purity	Phase
HY-148511	Vidutolimod		93.85%	Phase 3
HY-13902	Berzosertib		99.67%	Phase 2
HY-150724	ODN 1018	Agonist	99.28%	Phase 2
HY-13735H	Quinacrine acetate		/	Phase 2

Pre-clinical Phase

Bioactive Molecules (112)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-114180	RU.521	Inhibitor	99.95%	Unkown
HY-131454	SR-717	Agonist	99.89%	Unkown
HY-133916	G140	Inhibitor	99.17%	Unkown
HY-128583	G150	Inhibitor	99.20%	Unkown
HY-160225	ISD sodium		98.02%	Unkown
HY-150741	ODN 2216		98.57%	Unkown
HY-150751	ODN TTAGGG		99.87%	Unkown
HY-114182	PF-06928215	Inhibitor	99.68%	Unkown
HY-P1680	Astin C	Inhibitor	99.47%	Unkown
HY-150751C	ODN TTAGGG sodium	Antagonist	93.80%	Unkown
HY-W021040	Fludioxonil		99.94%	Unkown
HY-172208	PROTAC cGAS degrader-1	Degrader	99.07%	Unkown
HY-139056	SU0268	Inhibitor	99.96%	Unkown
HY-160546	cGAS-IN-2	Inhibitor	99.67%	Unkown
HY-150750	ODN M362		96.01%	Unkown
HY-P5997	XQ2B	Inhibitor	99.45%	Unkown
HY-149526	cGAS-IN-1	Inhibitor	98.21%	Unkown
HY-123230	Trifloxystrobin	Inhibitor	99.49%	Unkown
HY-164288	TDI-6570	Inhibitor	99.64%	Unkown
HY-114181	IRAK4-IN-4	Inhibitor	99.55%	Unkown
HY-170362	cGAS-IN-4	Inhibitor	99.28%	Unkown
HY-131454A	SR-717 free acid	Agonist	99.36%	Unkown
HY-124700	LYPLAL1-IN-1		99.9%	Unkown
HY-174801	XL-3156	Inhibitor	99.91%	Unkown
HY-B0821	Pymetrozine	Inhibitor	≥99.0%	Unkown
HY-116214	Cyprodinil		98.84%	Unkown
HY-141831	STF-1084	Inhibitor	99.92%	Unkown
HY-158045	PROTAC PARP1 degrader-1	Degrader	99.86%	Unkown
HY-174802	XL-3158	Inhibitor	99.55%	Unkown
HY-N2616	Vomicine	Inhibitor	99.85%	Unkown
HY-B1331	Cyromazine		99.79%	Unkown
HY-170362A	(R)-cGAS-IN-4	Control	99.94%	Unkown
HY-171692	G3-YSD		98.37%	Unkown
HY-RS02576	CGAS Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-177338	STING agonist-45	Agonist	99.10%	Unkown
HY-132221	CU-32	Inhibitor	98.8%	Unkown
HY-123230R	Trifloxystrobin (Standard)	Inhibitor	99.15%	Unkown
HY-116214R	Cyprodinil (Standard)		99.04%	Unkown
HY-150742	ODN 2336	Agonist	90.74%	Unkown
HY-150747	ODN 6016	Inducer	94.95%	Unkown
HY-150748	ODN D-SL01	Agonist	99.94%	Unkown
HY-160225F	Biotin-labeled ISD sodium		/	Unkown
HY-RS02577	Cgas Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W411604	tert-Butyl hex-5-ynoate		/	Unkown
HY-118578	Furalaxyl	Inhibitor	99.3%	Unkown
HY-12464	Butafenacil		98.99%	Unkown
HY-184095	Iptocigistat	Inhibitor	/	Unkown
HY-115763	3-Aminopropylphosphinic acid	Agonist	/	Unkown
HY-116214S	Cyprodinil-d5		/	Unkown
HY-116214S1	Cyprodinil-13C6		/	Unkown
HY-123230S	Trifloxystrobin-d6	Inhibitor	/	Unkown
HY-123230S1	Trifloxystrobin-d3		/	Unkown
HY-13902A	Berzosertib hydrochloride		98.77%	Unkown
HY-139678	SC13		/	Unkown
HY-144328	STING agonist-10	Activator	/	Unkown
HY-144329	STING agonist-11	Activator	/	Unkown
HY-147129	cGAS-IN-9	Inhibitor	/	Unkown
HY-148412	Monarsen	Inhibitor	/	Unkown
HY-150213	ODN BW001	Inhibitor	/	Unkown
HY-150751A	Biotin-labeled ODN TTAGGG sodium		/	Unkown
HY-150751B	FITC-labeled ODN TTAGGG sodium	Antagonist	/	Unkown
HY-158126	G-quadruplex ligand 2	Inhibitor	/	Unkown
HY-159925	QKY-613	Activator	98.24%	Unkown
HY-162459	cGAS-IN-3	Inhibitor	/	Unkown
HY-162944	NA-Ir		/	Unkown
HY-162966	MS7829	Activator	/	Unkown
HY-162967	MS8588	Degrader	/	Unkown
HY-163461	4F-DDC	Inhibitor	/	Unkown
HY-169225	PDIC-NN	Inducer	/	Unkown
HY-169225A	PDIC-NN dimethanesulfonate		/	Unkown
HY-172218	Lenalidomide-hex-5-ynoic acid		/	Unkown
HY-175472	(GalNAc)3-CPT		/	Unkown
HY-176256	endo-S-cGAFMP	Agonist	/	Unkown
HY-178032	PARP1-IN-44		/	Unkown
HY-178431	MT-44		/	Unkown
HY-179147	cGAS-IN-6	Inhibitor	/	Unkown
HY-179624	cGAS-IN-7	Inhibitor	/	Unkown
HY-180211	cGAS-IN-8	Inhibitor	/	Unkown
HY-180555	SN38-(PEG)2-Pom-α	Activator	/	Unkown
HY-181850	Telomeric G4s ligand 2		/	Unkown
HY-182360	Cytisine-platinum(IV) prodrug-1		/	Unkown
HY-182758	Topoisomerase I-IN-21		/	Unkown
HY-182926	Topoisomerase I/II-IN-9	Inhibitor	/	Unkown
HY-183748	XL-20		/	Unkown
HY-184398	cGAS/HDAC-IN-1	Inhibitor	/	Unkown
HY-184662	Ferroptosis inducer-17		/	Unkown
HY-B0621S	Triclabendazole-d3		/	Unkown
HY-B0621S1	Triclabendazole-13C,d3	Inhibitor	/	Unkown
HY-B1331S1	Cyromazine-13C3		/	Unkown
HY-N12507	Eupenicisirenin C	Inhibitor	/	Unkown
HY-N15159	Cladophorol A	Inhibitor	/	Unkown
HY-P3041	Chromostatin (bovine)	Inhibitor	/	Unkown
HY-P3864	Pancreastatin (37-52), human	Inhibitor	/	Unkown
HY-RS02575	CGA Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS02578	Cgas Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS02624	CHGA Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W020788	Benoxacor		99.39%	Unkown
HY-114730	CGA-JK3	Inhibitor	/	Unkown
HY-121165	Cymiazole		/	Unkown
HY-165620	Etacelasil		/	Unkown
HY-RS17789	Cga Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS18918	Chga Mouse Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-RS24257	Cga Rat Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W010319S	2-Amino-4-methoxy-6-methyl-1,3,5-triazine-d3		/	Unkown
HY-W021040S	Fludioxonil-13C3		/	Unkown
HY-W289054S	(S)-Metolachlor metabolite CGA 50720-d3		/	Unkown
HY-W681867	Fluxofenim		98.03%	Unkown
HY-W707416S	N-(2,6-Dimethylphenyl)-N-(2-(methoxy-d3)acetyl)alanine		/	Unkown
HY-W714168S	(rac)-Metolachlor metabolite CGA 351916-d3		/	Unkown
HY-W714705S	(S)-Metolachlor metabolite CGA 368208-d3 sodium salt		/	Unkown
HY-W722289S	(rac)-Metolachlor metabolite CGA 50267-d3		/	Unkown
HY-W751253	Dofenapyn		/	Unkown

Inhibitory Antibodies (1)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P990181	Anti-Mouse myeloperoxidase/MPO Antibody (6G4)	Inhibitor	95.00%	Unkown

Orthologs Information

Species	Symbol	Source	ID
Mus musculus	CGA	MGD	MGI:88390
Macaca mulatta	CGA	VGNC	VGNC:71021
Canis familiaris	CGA	VGNC	VGNC:39181
Rattus norvegicus	CGA	RGD	RGD:620436
Bos taurus	CGA	VGNC	VGNC:27257
Others	CGA	NCBI